Phibro Animal Health Corporation (PAHC) Stock
Phibro Animal Health stock price chart
PAHC stock quote & key statistics
Phibro Animal Health annual financials
Income statement →| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2026 | $1.52B | $99.7M | $3.21 |
| FY2025 | $1.30B | $48.3M | $2.09 |
| FY2024 | $1.02B | $2.4M | $1.19 |
| FY2023 | $977.9M | $32.6M | $1.22 |
| FY2022 | $942.3M | $49.2M | $1.31 |
Fiscal year ending June 30. Source: company filings via EODHD.
About Phibro Animal Health Corporation
Phibro Animal Health Corporation, headquartered in Teaneck, New Jersey, is a leading developer, manufacturer, and supplier of a comprehensive range of animal health and mineral nutrition products catering to both food and companion animals. Established in 1946 as Philipp Brothers Chemicals, Inc., the company rebranded to Phibro Animal Health Corporation in 2003, reflecting its specialization in advanced animal care solutions.
Operating across three key segments Animal Health, Mineral Nutrition, and Performance Products Phibro Animal Health offers a diverse portfolio designed to enhance the health and performance of various species including poultry, swine, beef and dairy cattle, aquaculture species, and dogs. Its extensive product lineup includes antibacterials and anticoccidials for disease prevention and treatment, anthelmintics to combat parasitic infections, and anti-bloat treatments for cattle grazing on legume or wheat-pasture.
In addition to its animal health offerings, Phibro manufactures and markets specialty nutritional products that optimize animal nutrition, thereby improving overall health and productivity. The company also produces formulations of trace minerals such as zinc, manganese, copper, and iron, vital for animal health and growth. These minerals find applications not only in animal nutrition but also in industries such as personal care, industrial chemicals, and chemical catalysts.
Phibro Animal Health Corporation distributes its products globally through a network of local sales offices, serving integrated poultry, swine, and cattle producers, as well as commercial animal feed manufacturers, wholesalers, and distributors. With a strong presence in the United States, Latin America, Canada, Europe, the Middle East, Africa, and the Asia Pacific region, Phibro continues to expand its footprint and innovate within the animal health and nutrition sectors, driving advancements that benefit both animal welfare and agricultural productivity worldwide.
Phibro Animal Health stock FAQ
What is the Phibro Animal Health stock ticker symbol?
Phibro Animal Health Corporation trades on the NASDAQ under the ticker symbol PAHC.
What sector and industry is Phibro Animal Health in?
Phibro Animal Health Corporation is classified in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry.
How many employees does Phibro Animal Health have?
Phibro Animal Health Corporation has about 2,605 full-time employees.
What were Phibro Animal Health's revenue and earnings last fiscal year?
Phibro Animal Health reported revenue of $1.52B and net income of $99.7M in fiscal 2026, with earnings per share of $3.21. Revenue grew 17.1% from the prior year.
Is Phibro Animal Health in the S&P SmallCap 600?
Yes. Phibro Animal Health Corporation (PAHC) is a component of the S&P SmallCap 600, the benchmark index of profitable U.S. small-cap stocks.
Is Phibro Animal Health in the Russell 2000?
Yes. Phibro Animal Health Corporation (PAHC) is a component of the Russell 2000, the benchmark index of U.S. small-cap stocks.
When did Phibro Animal Health go public?
Phibro Animal Health stock began trading on April 11, 2014.
S&P SmallCap 600 Healthcare stocks
All S&P SmallCap 600 →- ALKSAlkermes
- AMPHAmphastar Pharmaceuticals
- AMRXAmneal Pharmaceuticals
- ANIPANI Pharmaceuticals
- COLLCollegium Pharmaceutical
- CONConcentra Group Holdings Parent
- GKOSGlaukos
- ICUIICU Medical
- INDVIndivior
- ITGRInteger
- LGNDLigand Pharmaceuticals
- LQDALiquidia
- MMSIMerit Medical Systems
- OGNOrganon
- PBHPrestige Consumer Healthcare
- PCRXPacira BioSciences
- PRGOPerrigo
- PTCTPTC Therapeutics
- PTGXProtagonist Therapeutics
- RDNTRadNet
- SUPNSupernus Pharmaceuticals
- TFXTeleflex
- TGTXTG Therapeutics
- VCYTVeracyte